Liposomes Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Simple Liposomes, Formulated Liposomes, Vaccines); Application (Drug Delivery, Gene Delivery/Transfection, Contrast Agents for Medical Imaging, Model Cell Membranes); Distribution Channel (Retail Sales, Distributional Sales); and Geography

Report Code: TIPRE00021178 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

A spherical-shaped vesicle consists of one or more phospholipid bilayers such that it relates the structure of cell membranes, defined as a liposome. The lipid bilayers are hydrophobic and hydrophilic. The liposome targets a particular part or tissue instead of a whole-body part. Liposome serves as a tool and reproduction in many scientific disciplines, chemistry, biophysics, biochemistry, etc. Understanding of targeted drug delivery system has encouraged the market of liposomal drugs.

MARKET DYNAMICS

The increase in the understanding of targeted drug delivery system, and continuous research and development in design of liposome for new biotechnology products will spur the demand for liposomes market. Additionally, increase in the number of patients suffering from solid tumors and macrophages; and adoption of liposome in clinics due to low toxicity and high efficiency expected to boost the market growth to significant extent over the forecast period. However, Low solubility in body, high cost of production; and short half-life of liposome may restraint the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Liposomes Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of liposomes market with detailed market segmentation by product, application, distribution channel and geography. The global liposomes market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading liposomes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global liposomes market is segmented into product, application, and distribution channel. Based on product type, the global liposomes market is segmented into simple liposomes, formulated liposomes, and vaccines. Based on the application, the liposomes market is segmented into drug delivery, gene delivery/transfection, contrast agents for medical imaging, and model cell membranes. Based on the distribution channel, the liposomes market is retail sales, and distributional sales.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global liposomes market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The liposomes market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting liposomes market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the liposomes market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the liposomes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from liposomes market are anticipated to lucrative growth opportunities in the future with the rising demand for liposomes market in the global market. Below mentioned is the list of few companies engaged in the liposomes market.

The report also includes the profiles of key liposomes market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer Inc.
  •   Teva Pharmaceutical Industries Ltd.
  •   Novartis AG
  •   Johnson and Johnson
  •   Bristol Myers Squibb Company
  •   GlaxoSmithKline Plc
  •   SkyePharma Inc.
  •   Serum Institute of India Pvt. Ltd.
  •   Gilead Sciences, Inc.
  •   Luye Boston R and D IIC

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liposomes Market - By Product
1.3.2 Liposomes Market - By Application
1.3.3 Liposomes Market - By Distribution Channel
1.3.4 Liposomes Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIPOSOMES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIPOSOMES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIPOSOMES MARKET - GLOBAL MARKET ANALYSIS
6.1. LIPOSOMES - GLOBAL MARKET OVERVIEW
6.2. LIPOSOMES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LIPOSOMES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SIMPLE LIPOSOMES
7.3.1. Overview
7.3.2. Simple Liposomes Market Forecast and Analysis
7.4. FORMULATED LIPOSOMES
7.4.1. Overview
7.4.2. Formulated Liposomes Market Forecast and Analysis
7.4.3. Doxorubicin Liposomes Market
7.4.3.1. Overview
7.4.3.2. Doxorubicin Liposomes Market Forecast and Analysis
7.4.4. Amphotericin B Liposomes Market
7.4.4.1. Overview
7.4.4.2. Amphotericin B Liposomes Market Forecast and Analysis
7.4.5. Paclitaxel Liposomes Market
7.4.5.1. Overview
7.4.5.2. Paclitaxel Liposomes Market Forecast and Analysis
7.4.6. Cytarabine Liposomes Market
7.4.6.1. Overview
7.4.6.2. Cytarabine Liposomes Market Forecast and Analysis
7.4.7. Irinotecan Liposomes Market
7.4.7.1. Overview
7.4.7.2. Irinotecan Liposomes Market Forecast and Analysis
7.4.8. Cisplatin Liposomes Market
7.4.8.1. Overview
7.4.8.2. Cisplatin Liposomes Market Forecast and Analysis
7.4.9. Others Market
7.4.9.1. Overview
7.4.9.2. Others Market Forecast and Analysis
7.5. VACCINES
7.5.1. Overview
7.5.2. Vaccines Market Forecast and Analysis
8. LIPOSOMES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DELIVERY
8.3.1. Overview
8.3.2. Drug Delivery Market Forecast and Analysis
8.3.3. Cancer Market
8.3.3.1. Overview
8.3.3.2. Cancer Market Forecast and Analysis
8.3.4. Fungal Infection Market
8.3.4.1. Overview
8.3.4.2. Fungal Infection Market Forecast and Analysis
8.3.5. Viral and Parasite Infections Market
8.3.5.1. Overview
8.3.5.2. Viral and Parasite Infections Market Forecast and Analysis
8.3.6. Others Market
8.3.6.1. Overview
8.3.6.2. Others Market Forecast and Analysis
8.4. GENE DELIVERY/TRANSFECTION
8.4.1. Overview
8.4.2. Gene Delivery/Transfection Market Forecast and Analysis
8.5. CONTRAST AGENTS FOR MEDICAL IMAGING
8.5.1. Overview
8.5.2. Contrast Agents for Medical Imaging Market Forecast and Analysis
8.6. MODEL CELL MEMBRANES
8.6.1. Overview
8.6.2. Model Cell Membranes Market Forecast and Analysis
9. LIPOSOMES MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL SALES
9.3.1. Overview
9.3.2. Retail Sales Market Forecast and Analysis
9.3.3. Academic and Research Laboratories Market
9.3.3.1. Overview
9.3.3.2. Academic and Research Laboratories Market Forecast and Analysis
9.3.4. Biopharmaceutical Companies Market
9.3.4.1. Overview
9.3.4.2. Biopharmaceutical Companies Market Forecast and Analysis
9.3.5. Clinical Research Organizations Market
9.3.5.1. Overview
9.3.5.2. Clinical Research Organizations Market Forecast and Analysis
9.3.6. Others Market
9.3.6.1. Overview
9.3.6.2. Others Market Forecast and Analysis
9.4. DISTRIBUTIONAL SALES
9.4.1. Overview
9.4.2. Distributional Sales Market Forecast and Analysis
9.4.3. Hospital Pharmacies Market
9.4.3.1. Overview
9.4.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4.4. Retail Pharmacies Market
9.4.4.1. Overview
9.4.4.2. Retail Pharmacies Market Forecast and Analysis
9.4.5. Mail Order Pharmacies Market
9.4.5.1. Overview
9.4.5.2. Mail Order Pharmacies Market Forecast and Analysis
9.4.6. Drug Stores Market
9.4.6.1. Overview
9.4.6.2. Drug Stores Market Forecast and Analysis
10. LIPOSOMES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Liposomes Market Overview
10.1.2 North America Liposomes Market Forecasts and Analysis
10.1.3 North America Liposomes Market Forecasts and Analysis - By Product
10.1.4 North America Liposomes Market Forecasts and Analysis - By Application
10.1.5 North America Liposomes Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Liposomes Market Forecasts and Analysis - By Countries
10.1.6.1 United States Liposomes Market
10.1.6.1.1 United States Liposomes Market by Product
10.1.6.1.2 United States Liposomes Market by Application
10.1.6.1.3 United States Liposomes Market by Distribution Channel
10.1.6.2 Canada Liposomes Market
10.1.6.2.1 Canada Liposomes Market by Product
10.1.6.2.2 Canada Liposomes Market by Application
10.1.6.2.3 Canada Liposomes Market by Distribution Channel
10.1.6.3 Mexico Liposomes Market
10.1.6.3.1 Mexico Liposomes Market by Product
10.1.6.3.2 Mexico Liposomes Market by Application
10.1.6.3.3 Mexico Liposomes Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Liposomes Market Overview
10.2.2 Europe Liposomes Market Forecasts and Analysis
10.2.3 Europe Liposomes Market Forecasts and Analysis - By Product
10.2.4 Europe Liposomes Market Forecasts and Analysis - By Application
10.2.5 Europe Liposomes Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Liposomes Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Liposomes Market
10.2.6.1.1 Germany Liposomes Market by Product
10.2.6.1.2 Germany Liposomes Market by Application
10.2.6.1.3 Germany Liposomes Market by Distribution Channel
10.2.6.2 France Liposomes Market
10.2.6.2.1 France Liposomes Market by Product
10.2.6.2.2 France Liposomes Market by Application
10.2.6.2.3 France Liposomes Market by Distribution Channel
10.2.6.3 Italy Liposomes Market
10.2.6.3.1 Italy Liposomes Market by Product
10.2.6.3.2 Italy Liposomes Market by Application
10.2.6.3.3 Italy Liposomes Market by Distribution Channel
10.2.6.4 Spain Liposomes Market
10.2.6.4.1 Spain Liposomes Market by Product
10.2.6.4.2 Spain Liposomes Market by Application
10.2.6.4.3 Spain Liposomes Market by Distribution Channel
10.2.6.5 United Kingdom Liposomes Market
10.2.6.5.1 United Kingdom Liposomes Market by Product
10.2.6.5.2 United Kingdom Liposomes Market by Application
10.2.6.5.3 United Kingdom Liposomes Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Liposomes Market Overview
10.3.2 Asia-Pacific Liposomes Market Forecasts and Analysis
10.3.3 Asia-Pacific Liposomes Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Liposomes Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Liposomes Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Liposomes Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Liposomes Market
10.3.6.1.1 Australia Liposomes Market by Product
10.3.6.1.2 Australia Liposomes Market by Application
10.3.6.1.3 Australia Liposomes Market by Distribution Channel
10.3.6.2 China Liposomes Market
10.3.6.2.1 China Liposomes Market by Product
10.3.6.2.2 China Liposomes Market by Application
10.3.6.2.3 China Liposomes Market by Distribution Channel
10.3.6.3 India Liposomes Market
10.3.6.3.1 India Liposomes Market by Product
10.3.6.3.2 India Liposomes Market by Application
10.3.6.3.3 India Liposomes Market by Distribution Channel
10.3.6.4 Japan Liposomes Market
10.3.6.4.1 Japan Liposomes Market by Product
10.3.6.4.2 Japan Liposomes Market by Application
10.3.6.4.3 Japan Liposomes Market by Distribution Channel
10.3.6.5 South Korea Liposomes Market
10.3.6.5.1 South Korea Liposomes Market by Product
10.3.6.5.2 South Korea Liposomes Market by Application
10.3.6.5.3 South Korea Liposomes Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Liposomes Market Overview
10.4.2 Middle East and Africa Liposomes Market Forecasts and Analysis
10.4.3 Middle East and Africa Liposomes Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Liposomes Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Liposomes Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Liposomes Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Liposomes Market
10.4.6.1.1 South Africa Liposomes Market by Product
10.4.6.1.2 South Africa Liposomes Market by Application
10.4.6.1.3 South Africa Liposomes Market by Distribution Channel
10.4.6.2 Saudi Arabia Liposomes Market
10.4.6.2.1 Saudi Arabia Liposomes Market by Product
10.4.6.2.2 Saudi Arabia Liposomes Market by Application
10.4.6.2.3 Saudi Arabia Liposomes Market by Distribution Channel
10.4.6.3 U.A.E Liposomes Market
10.4.6.3.1 U.A.E Liposomes Market by Product
10.4.6.3.2 U.A.E Liposomes Market by Application
10.4.6.3.3 U.A.E Liposomes Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Liposomes Market Overview
10.5.2 South and Central America Liposomes Market Forecasts and Analysis
10.5.3 South and Central America Liposomes Market Forecasts and Analysis - By Product
10.5.4 South and Central America Liposomes Market Forecasts and Analysis - By Application
10.5.5 South and Central America Liposomes Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Liposomes Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Liposomes Market
10.5.6.1.1 Brazil Liposomes Market by Product
10.5.6.1.2 Brazil Liposomes Market by Application
10.5.6.1.3 Brazil Liposomes Market by Distribution Channel
10.5.6.2 Argentina Liposomes Market
10.5.6.2.1 Argentina Liposomes Market by Product
10.5.6.2.2 Argentina Liposomes Market by Application
10.5.6.2.3 Argentina Liposomes Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIPOSOMES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LIPOSOMES MARKET, KEY COMPANY PROFILES
13.1. PFIZER INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NOVARTIS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JOHNSON AND JOHNSON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BRISTOL MYERS SQUIBB COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SKYEPHARMA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SERUM INSTITUTE OF INDIA PVT. LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GILEAD SCIENCES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. LUYE BOSTON R AND D IIC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Teva Pharmaceutical Industries Ltd.
3. Novartis AG
4. Johnson and Johnson
5. Bristol Myers Squibb Company
6. GlaxoSmithKline Plc
7. SkyePharma Inc.
8. Serum Institute of India Pvt. Ltd.
9. Gilead Sciences, Inc.
10. Luye Boston R and D IIC
11. Sun Pharmaceutical Industries Ltd
12. Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd
13. CELSION, Inc.,
14. Abbott
15. Ipsen Pharma
16. Spectrum Pharmaceuticals, Inc.
17. Pacira BioSciences, Inc.
18. Takeda Pharmaceutical Company Limited
19. Astellas Pharma, Inc.
20. Sigma-Tau Group
TIPRE00021178
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking